Article Information
History
- August 26, 2020.
Article Versions
- You are currently viewing Version 1 of this article (August 26, 2020 - 05:25).
- Version 2 (August 27, 2020 - 19:27).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jean-Philippe Rasigade1,2,*,
- Anaïs Barray1,
- Julie Teresa Shapiro1,
- Charlène Coquisart3,4,
- Yoann Vigouroux3,4,
- Antonin Bal1,2,5,
- Grégory Destras1,2,5,
- Philippe Vanhems1,6,
- Bruno Lina1,2,5,
- Laurence Josset1,2,5 and
- Thierry Wirth3,4,*
- 1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
- 2Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon 69004, France
- 3Institut de Systématique, Evolution, Biodiversité (ISYEB), Muséum national d’Histoire naturelle, CNRS, Sorbonne Université, Université des Antilles, EPHE, Paris 75005, France
- 4PSL University, EPHE, Paris 75014, France
- 5Centre National de Référence des Virus Respiratoires, Hospices Civils de Lyon, Lyon 69004, France
- 6Service d’Hygiène, Epidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon (HCL), Lyon 69008, France
- ↵*Correspondence to: jean-philippe.rasigade{at}univ-lyon1.fr and wirth{at}mnhn.fr
Posted August 26, 2020.
SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions
